臺北榮民總醫院

:::

吳崇暉 (Tsung-Hui Wu)

掛號

[簡介]

學歷
經歷
現職：
- - 迄今臺北榮民總醫院內分泌新陳代謝科主治醫師
- - 迄今國立陽明交通大學醫學系內科學科講師
經歷：
- - 臺北榮民總醫院內科部住院醫師
- - 臺北榮民總醫院內科部內分泌新陳代謝科住院總醫師
醫療專長
1. 內分泌疾病
2. 代謝疾病
證照

中華民國內分泌暨糖尿病專科醫師中華民國內科專科醫師臺北市糖尿病共同照護網認證醫師

[著作]

1. Wu TH, Tsai SC, Lin HW, Chen CN, Hwu CM. Increased serum levels of advanced glycation end products are negatively associated with relative muscle strength in patients with type 2 diabetes mellitus. BMC Endocr Disord. 2022;22(1):118.
2. Wu TH, Chang LH, Chu CH, Hwu CM, Chen HS, Lin LY. Soluble tumor necrosis factor receptor 2 is associated with progressive diabetic kidney disease in patients with type 2 diabetes mellitus. PLoS One. 2022;17(4):e0266854.
3. Wu TH, Lee IT, Ho LT, Sheu WH, Hwu CM. Combined lipid goal attainment in patients with type 2 diabetes and dyslipidemia: A head-to-head comparative trial of statins. J Chin Med Assoc. 2022;85(8):831-38.
4. Wu TH, Lin YC, Hwu CM. Ten-year atherosclerotic cardiovascular disease risk prediction for postmenopausal women: Impacts of isolated postchallenge hyperglycemia. Medicine (Baltimore). 2022;101(36):e30352.
5. Wu TH, Su GY, Liu TY, Wang HT, Hwu CM. Urinary acrolein protein conjugates-to-creatinine ratio is positively associated with diabetic peripheral neuropathy in patients with type 2 diabetes mellitus. Endocr Connect. 2023:EC-23-0253.